Liver Diseases  >>  Roferon A (recombinant interferon alfa-2a)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Roferon A (recombinant interferon alfa-2a) / Roche
DNA-EVAL, NCT00199732: Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a

Completed
N/A
19
Europe
University Hospital, Limoges, Hoffmann-La Roche
Chronic Hepatitis B
07/09
07/09
NCT01861444: An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)

Terminated
N/A
45
Europe
Hoffmann-La Roche
Hepatitis D, Chronic
03/15
03/15

Download Options